Malaysian Avarev company delegation visited and inspected the Yinfeng Life Science Foundation in Shandong Province
Release time:
2018-03-12
On March 12, 2018, five members led by Jones Bartholomew, CEO of Avarev Malaysia, visited and inspected the Yinfeng Life Science Foundation in Shandong Province. Song Xianshou, President of Yinfeng Biotechnology Group, and Pang Yong, Vice President, accompanied the exchange.

The delegation visited Shandong Provincial Cord Blood Bank and Shandong Yinfeng Life Science Research Institute, and gained a detailed understanding of the progress, technical strength, possibility of technological output, and laws and regulations of the foundation's funded project - Life Extension Plan. They also witnessed Yinfeng's qualifications and research achievements in cell tissue low-temperature preservation, low-temperature medical equipment research and development, and other aspects.
After the visit, both sides had a friendly discussion. Song Xianshou, the President of Yinfeng Biotechnology Group, introduced the industrial distribution of Yinfeng Biotechnology Group in the field of biomedical science. He hoped that both sides could combine their own characteristics and advantages to carry out in-depth cooperation and jointly promote the development of life sciences. Avarev stated that Yinfeng Biotech Group has made remarkable progress in the field of life sciences, with the Life Continuation Research Program leading the world's innovation trend. We look forward to further cooperation between the two parties and hope to have further communication and discussion in specific areas of cooperation in the future.
Latest developments
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.